Panacea Biotec Limited, a biotechnology company, researches and develops, manufactures, markets, and sells pharmaceuticals, vaccines, and biosimilar in India. The company operates through Vaccines, Formulations, and Research and Development segments. Its product portfolio includes prescription products in various therapeutic areas, including pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care products, as well as vaccines. The company also exports its products to the Commonwealth of Independent States, Africa, the Middle East, and Asia. It has a collaboration agreement with Refana Inc. for the development, manufacturing, and distribution of the Covid-19 vaccine. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India. The ISIN of this stock is INE922B01023.